Latest 10-K annual reports

GivBux Inc.'s 2024 10-K filing highlights a significant increase in revenue driven by transactional and subscription growth, alongside a substantial net loss due to increased operating expenses and stock-based compensation.

Koil Energy Solutions, Inc. reports a 48% increase in revenue for 2024, driven by fixed price contracts, but identifies material weaknesses in internal control over financial reporting.

Blaize Holdings, Inc. files its 2024 10-K, detailing its business strategy, financial performance, and risk factors following its merger with BurTech Acquisition Corporation.

IMAC Holdings transitions to proteomic services, acquiring Theralink assets, while grappling with Nasdaq delisting due to Minimum Equity Rule non-compliance.

Applied Therapeutics receives a Complete Response Letter from the FDA for its Galactosemia drug, prompting a strategic shift towards Sorbitol Dehydrogenase (SORD) Deficiency treatment.

Yunhong Green CTI Ltd.'s 2024 Form 10-K reveals strategic shifts, financial challenges, and efforts to maintain NASDAQ listing compliance.

Pioneer Power Solutions reports a significant increase in revenue for its Critical Power segment, driven by mobile EV charging solutions, despite identifying a material weakness in internal controls.

Papaya Growth Opportunity Corp. I's 10-K filing reveals a company struggling to find a business combination target as its deadline approaches, shares delist, and redemptions deplete its trust account.

Nexalin Technology files an amendment to its 2024 annual report to include the Insider Trading Policy and Compensation Recoupment Policy exhibits.

CareView Communications files an amendment to its annual report on Form 10-K to revise information regarding the security ownership of certain beneficial owners and management.

Cyber Enviro-Tech, Inc. reports a net loss of $6.37 million for 2024, driven by increased asset impairment and operating expenses, as the company focuses on water and oil remediation and plans to spin off its Alvey oil field.

iSpecimen Inc.'s annual report reveals a net loss of $12.5 million for 2024 and raises substantial doubt about the company's ability to continue as a going concern.

Healthier Choices Management Corp. (HCMC) reports its fiscal year 2024 results, highlighting the spin-off of its grocery segment, ongoing patent litigation, and efforts to manage its intellectual property portfolio.

Nukkleus Inc. files an amendment to its annual report to include information on its policy for recovering erroneously awarded compensation, while also detailing its business strategy, recent developments, and financial performance.

Contango Ore, Inc. files an amendment to its annual report to include its policy regarding the mandatory recovery of compensation from executive officers in the event of a financial restatement.

Two Hands Corporation reports a net loss for fiscal year 2024 and announces a strategic shift away from wholesale food distribution to focus on artisan denim and premium cotton yarns.

Skinvisible, Inc. files its 10-K for the year ended December 31, 2024, highlighting ongoing efforts to license its Invisicare technology and advancements in clinical trials by its licensee, Quoin Pharmaceuticals.

Emmaus Life Sciences' 10-K filing reveals a significant revenue drop in 2024 and raises substantial doubt about the company's ability to continue as a going concern.

REMSleep Holdings, Inc. reports a net loss for 2024 but recognizes revenue from ResPlus CPAP system sales and continues development of its DeltaWave product.

Stran & Company's 2024 10-K filing reveals an 8.8% increase in sales offset by a net loss due to rising operating expenses, acquisition costs, and identified material weaknesses in internal controls.

AlphaVest Acquisition Corp's latest 10-K filing reveals substantial doubt about its ability to continue as a going concern due to its dependence on completing a business combination and a looming liquidation deadline.

Merit Medical Systems has filed an amendment to its annual report to correct the five-year cumulative total return information for NASDAQ Stocks within its original filing.

Skillsoft Corp. outlines the terms and conditions for performance stock unit grants under its 2020 Omnibus Incentive Plan.

Ontrak, Inc.'s 2024 10-K filing reveals a net loss of $25.49 million and raises substantial doubt about the company's ability to continue as a going concern due to recurring losses and the need for additional capital.

GT Biopharma files an amendment to its 2024 Form 10-K to include the company's Compensation Recovery Policy as an exhibit.

TOMI Environmental Solutions reports a 5% increase in annual revenue for 2024, but acknowledges substantial doubt about its ability to continue as a going concern due to recurring losses and limited cash reserves.

Currenc Group Inc. reports its financial results for the year ended December 31, 2024, highlighting key financial metrics and strategic developments after its business combination.

DarkPulse Inc.'s 2024 10-K filing reveals a net loss, decreased revenues, and ongoing efforts to secure additional financing amid substantial doubt about its ability to continue as a going concern.

Free Flow USA Inc.'s 2024 annual report reveals a revenue increase and a shift to net income, driven by asset sales and trading activities.

Elvictor Group, Inc. announces a net income of $199,780 for the year ended December 31, 2024, a significant turnaround from the previous year's net loss, driven by increased revenues and reduced operating expenses.